ALA to Promote Awareness of Progressive Pulmonary Fibrosis
On World Interstitial Lung Disease Day, the American Lung Association launched an initiative to helping PPF patients and caregivers recognize worsening symptoms and lung scarring.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
Oral Bacterial Extract Fails to Prevent Asthma in High-Risk Children
A multiyear clinical trial found that OM-85 did not reduce severe wheezing episodes or early childhood asthma diagnoses.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
FDA Approves Updated COVID-19 Vaccines for 2026-2027
Updated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk populations.
Pharmaceuticals
Latest
Application Accepted for Inhaled Pulmonary Fibrosis Treatment
If cleared by federal regulators, nebulized Tyvaso (treprostinil) Inhalation Solution would become the first inhaled option designed to treat idiopathic pulmonary fibrosis (IPF).
Diagnostics & Testing
Latest
Increasing Use of Oscillometry for Lung Testing
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
Monitoring & Treatment
Latest
Early Alert for NOxBox Nitric Oxide Delivery System
NOxBox reported complaints of oxygen leaks due to failure of the oxygen tubing or tubing connection within the NOxMixer module of the NOxBoxi device, according to the FDA.